Skip to main content

Published locations for Cabozantinib boosts survival for some patients with RET+ medullary thyroid cancer

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Cabozantinib boosts survival for some patients with RET+ medullary thyroid cancer

User login

  • Reset your password
  • /content/cabozantinib-boosts-survival-some-patients-ret-medullary-thyroid-cancer
  • /familypracticenews/article/103667/head-neck-cancers/cabozantinib-boosts-survival-some-patients-ret
  • /internalmedicinenews/article/103667/head-neck-cancers/cabozantinib-boosts-survival-some-patients-ret
  • /oncologypractice/article/103667/head-neck-cancers/cabozantinib-boosts-survival-some-patients-ret
  • /clinicalendocrinologynews/article/103667/head-neck-cancers/cabozantinib-boosts-survival-some
  • /hematology-oncology/article/103667/head-neck-cancers/cabozantinib-boosts-survival-some-patients-ret
  • /endocrinology/article/103667/head-neck-cancers/cabozantinib-boosts-survival-some-patients-ret
  • /internalmedicine/article/103667/head-neck-cancers/cabozantinib-boosts-survival-some-patients-ret
  • /familymedicine/article/103667/head-neck-cancers/cabozantinib-boosts-survival-some-patients-ret